Is fixed severe pulmonary hypertension still a contraindication to heart transplant in the modern era of mechanical circulatory support? A review

Journal of Cardiovascular Medicine

Volumn 9, Issue 10, 2008, Pages 1059-1062

  Andrea, Garatti ^a   Giuseppe, Bruschi ^b   Tiziano, Colombo ^b   Maria, Frigerio ^b   Ettore, Vitali ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Heart transplantation; Left ventricular assist device; Pulmonary hypertension

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; LUNG VASCULAR RESISTANCE; MALE; MEDICAL LITERATURE; PULMONARY HYPERTENSION; TREATMENT CONTRAINDICATION; COST BENEFIT ANALYSIS; DRUG CONTRAINDICATION; DRUG RESISTANCE; ECONOMICS; HEART ASSIST DEVICE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; COST-BENEFIT ANALYSIS; DRUG RESISTANCE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 55249123869     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f64249     Document Type: Article

References (19)

1. Chen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 1997; 114:627-634.
2. Martin J, Siegenthaler MP, Friesewinkel O, Fader T, van de Loo A, Trummer G, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation - a preliminary study. Eur J Cardiothorac Surg 2004; 25: 971-977.
3. Gallagher RC, Kormos RL, Gasior T, Murali S, Griffith BP, Hardesty RL. Univentricular support results in reduction of pulmonary resistance and improved right ventricular function. ASAIO Trans 1991; 37:287-288.
4. Smedira NG, Dasse KA, Patel AN, Vargo RL, Massad MG, McCarthy PM. Age related outcome after implantable left ventricular assist system support. ASA/O J 1996; 42:M570-M573.
5. Adamson RM, Dembitsky WP, Jaski BE, Daily PO, Moreno R, Kim JC, et al. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASA/O J 1997; 43:365- 369.
6. Nguyen DQ, Ormaza S, Miller LW, Bittner HB, Rose AG, Bolman RM III, Park SJ. Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failure [abstract]. J Heart Lung Transplant 2001; 20:190.
7. Petrofski JA, Hoopes CW, Bashore TM, Russell SD, Milano CA. Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease. Ann Thorac Surg 2003; 75:1005-1007.
8. Al-Khaldi A, Ergina P, DeVarennes B, Lachappelle K, Cecere R. Left ventricular unloading in a patient with end-stage cardiomyopathy and medically unresponsive pulmonary hypertension. Artif Organs 2004; 28:158-160.
9. SalzbergSP, Lachat ML, von Harbou K,Zünd G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardio-Thorac Surg 2005; 27:222-225.
10. Etz CD, Di Luozzo G, Bello R, Luehr M, Khan MZ, Bodian CA, et al. Pulmonary complications after descending thoracic and thoracoabdominal aortic aneurysm repair: predictors, prevention, and treatment. Ann Thorac Surg 2007; 83:S870-S876; [discussion S890-S892].
11. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007; 133:689- 695.
12. Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, Sanchez V, Escribano P, Hernandez-Alfonso J, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant 2001; 20:942-948.
13. Radovancevic B, Vrtovec B, Thomas CD, Croitoru M, Myers T, Radovancevic R, et al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. J Heart Lung Transplant 2005; 24:690-695.
14. Bleasdale RA, Banner NR, Anyanwu AC, Mitchell AG, Khaghani A, Yacoub MH, et al. Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant 2002; 21:867-873.
15. Klotz S, Deng MC, Stypmann J, Roetker J, Wilhelm MJ, Hammel D, et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg 2004; 77:143-149.
16. Kingsbury MP, Huang W, Donnelly JL, Jackson E, Needham E, Turner MA, Sheridan DJ. Structural remodelling of lungs in chronic heart failure. Basic Res Cardiol 2003; 98:295-303.
17. Todorovich-Hunter L, Dodo H, Ye C, McCready L, Keeley FW, Rabinovitch M, et al. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am Rev Respir Dis 1992; 146:213-223.
18. Dang NC, Topkara VK, Mercando M, Kay J, Kruger K, Aboodi M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25: 1-6.
19. Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 2005; 24:200-204.